-
Arcutis Biotherapeutics (NASDAQ:ARQT) Receives "Buy" Rating from Guggenheim
ソース: Buzz FX / 24 2 2025 09:37:18 America/Chicago
Arcutis Biotherapeutics (NASDAQ:ARQT) Receives "Buy" Rating from Guggenheim Written by MarketBeat February 24, 2025 Share Link copied to clipboard. Arcutis Biotherapeutics ( NASDAQ:ARQT - Get Free Report ) 's stock had its "buy" rating reit
Read more...